Pharmafile - Manufacturing and Production News
The FDA has granted priority review of a supplemental new drug application (sNDA) for Evrysdi (risdiplam), to expand the indication to include pre-...
Spago Nanomedical AB announced new clinical and preclinical results for the company’s leading candidate drug, Tumorad® (177Lu-SN201). In a...
UCB announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorisation for BIMZELX (bimekizumab) for the...
The FDA has shared that it is limiting the use of two monoclonal antibody therapies for the treatment of COVID-19, due to data indications the...
Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with unresectable or...
Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment of HER2 positive...
Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral treatments...
Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This...
CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years and above, who have...
Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted the firm to exercise...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
